Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **lower esophageal sphincter** is a specialized region of involuntary smooth muscle located at the junction between the esophagus and stomach. Its primary function is to act as a barrier that prevents gastric contents from refluxing into the esophagus. The LES remains closed except during swallowing, when it relaxes briefly to allow food and liquids to pass into the stomach. Dysfunction or weakness in this sphincter is associated with conditions such as gastroesophageal reflux disease (GERD), achalasia, and hiatal hernia[1][3][5]. The LES is sometimes referred to by alternative names including "gastroesophageal sphincter," "gastroesophageal junction," or "cardiac sphincter" due to its anatomical location near the heart[1][3]. It is classified anatomically rather than molecularly—unlike receptors or enzymes—and thus does not fit standard definitions for therapeutic drug targets like proteins or genes. **Note:** The lower esophageal sphincter is an anatomical structure composed of smooth muscle fibers rather than a discrete molecule/receptor/protein. It does not meet criteria for typical drug targets used in pharmacology databases; therefore, it should be flagged as an incorrect entry if searching for canonical molecular targets[1][3][8].
Not applicable; drugs do not directly target the LES as a molecular entity but may influence its tone or the consequences of its dysfunction.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lower esophageal sphincter (LES).